[go: up one dir, main page]

PT946146E - Utilizacao de composicoes farmaceuticas aquosas para a producao de aerossois isentos de gas propulsante - Google Patents

Utilizacao de composicoes farmaceuticas aquosas para a producao de aerossois isentos de gas propulsante

Info

Publication number
PT946146E
PT946146E PT97952949T PT97952949T PT946146E PT 946146 E PT946146 E PT 946146E PT 97952949 T PT97952949 T PT 97952949T PT 97952949 T PT97952949 T PT 97952949T PT 946146 E PT946146 E PT 946146E
Authority
PT
Portugal
Prior art keywords
propulsant
aerosols
free
gas
production
Prior art date
Application number
PT97952949T
Other languages
English (en)
Inventor
Bernhard Freund
Bernd Zierenberg
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7815979&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT946146(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PT946146E publication Critical patent/PT946146E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
PT97952949T 1996-12-20 1997-12-16 Utilizacao de composicoes farmaceuticas aquosas para a producao de aerossois isentos de gas propulsante PT946146E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19653969A DE19653969A1 (de) 1996-12-20 1996-12-20 Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole

Publications (1)

Publication Number Publication Date
PT946146E true PT946146E (pt) 2003-08-29

Family

ID=7815979

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97952949T PT946146E (pt) 1996-12-20 1997-12-16 Utilizacao de composicoes farmaceuticas aquosas para a producao de aerossois isentos de gas propulsante

Country Status (39)

Country Link
US (3) US20010008632A1 (pt)
EP (2) EP0946146B1 (pt)
JP (1) JP4659160B2 (pt)
KR (1) KR100496723B1 (pt)
CN (1) CN1097455C (pt)
AR (1) AR008721A1 (pt)
AT (1) ATE235887T1 (pt)
AU (1) AU740543B2 (pt)
BG (1) BG64433B1 (pt)
BR (1) BRPI9713596C1 (pt)
CA (1) CA2275392C (pt)
CO (1) CO4920211A1 (pt)
DE (2) DE19653969A1 (pt)
DK (1) DK0946146T3 (pt)
EE (1) EE03949B1 (pt)
EG (1) EG23981A (pt)
ES (1) ES2196388T3 (pt)
HK (1) HK1022846A1 (pt)
HR (1) HRP970694B1 (pt)
HU (2) HU228494B1 (pt)
ID (1) ID22481A (pt)
IL (1) IL130464A (pt)
MY (1) MY124547A (pt)
NO (1) NO320652B1 (pt)
NZ (1) NZ336825A (pt)
PE (1) PE32899A1 (pt)
PL (1) PL189511B1 (pt)
PT (1) PT946146E (pt)
RS (1) RS49803B (pt)
RU (1) RU2219906C2 (pt)
SA (1) SA97180756B1 (pt)
SI (1) SI0946146T1 (pt)
SK (1) SK282910B6 (pt)
TR (1) TR199901408T2 (pt)
TW (1) TW438605B (pt)
UA (1) UA64736C2 (pt)
UY (1) UY24813A1 (pt)
WO (1) WO1998027959A2 (pt)
ZA (1) ZA9711370B (pt)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615422A1 (de) 1996-04-19 1997-11-20 Boehringer Ingelheim Kg Zweikammer-Kartusche für treibgasfreie Dosieraerosole
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
DE19808295A1 (de) 1998-02-27 1999-11-11 Boehringer Ingelheim Int Behälter für eine medizinische Flüssigkeit
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
SE9803770D0 (sv) * 1998-11-05 1998-11-05 Astra Ab Dry powder pharmaceutical formulation
DE19940713A1 (de) 1999-02-23 2001-03-01 Boehringer Ingelheim Int Kartusche für eine Flüssigkeit
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20100197719A1 (en) * 1999-05-12 2010-08-05 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
US20040002548A1 (en) * 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
AU2001294808A1 (en) * 2000-09-29 2002-04-08 Board Of Trustees Operating Michigan State University Catecholamine pharmaceutical compositions and methods
CN1237970C (zh) * 2000-10-31 2006-01-25 贝林格尔英格海姆法玛两合公司 含提欧川平盐的溶液的可吸入制剂
US20020137764A1 (en) 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
EA007604B1 (ru) * 2000-10-31 2006-12-29 Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг Ингаляционная композиция в виде раствора с солью тиотропия
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
DE10111843A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
DE10136555A1 (de) 2001-07-27 2003-02-13 Boehringer Ingelheim Int Optimierte Verfahren zur Bestimmung der Aerosol-Partikelgrößenverteilung und Vorrichtung zur Durchführung derartiger Verfahren
DE60209511T2 (de) * 2001-09-18 2006-10-05 Nycomed Danmark Aps Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
JP2010184937A (ja) * 2001-10-26 2010-08-26 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する１容器を作成する方法、および、吸入溶液を作成する方法
AU3297402A (en) * 2001-10-26 2003-10-30 Dey, L.P. An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
JP2006513129A (ja) * 2001-10-26 2006-04-20 デイ エルピー 小児喘息の症状を緩和するためのアルブテロール吸入溶液、システム、キット及び方法
US7754242B2 (en) * 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
US20040019073A1 (en) * 2002-04-11 2004-01-29 Boehringer Ingelheim Pharma Gmbh Co. Kg Aerosol formulation for inhalation containing a tiotropium salt
DE10216036A1 (de) * 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
US20050220720A1 (en) * 2002-05-02 2005-10-06 David Edwards Formulations limiting spread of pulmonary infections
AU2003243191B2 (en) 2002-05-02 2007-09-20 President And Fellows Of Harvard College Formulations limiting spread of pulmonary infections
US20040048886A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
EA009936B1 (ru) * 2002-08-14 2008-04-28 Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг Аэрозольная композиция для ингаляции, содержащая антихолинергическое средство
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
GB2400554B (en) * 2003-04-16 2007-04-18 George Margetts Treatment of angiotensin II-induced cardiovascular disease
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
US20050042176A1 (en) * 2003-07-28 2005-02-24 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising a novel anticholinergic and a steroid
US20050107417A1 (en) * 2003-07-28 2005-05-19 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising a novel anticholinergic and a betamimetic
US20050025718A1 (en) * 2003-07-31 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
US20050059643A1 (en) * 2003-08-05 2005-03-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising a steroid and a betamimetic
DE102004001451A1 (de) 2004-01-08 2005-08-11 Boehringer Ingelheim International Gmbh Vorrichtung zum Haltern eines fluidischen Bauteiles
US20050203088A1 (en) * 2004-01-09 2005-09-15 Boehringer Ingelheim International Gmbh Medicament combinations based on scopine- or tropene acid esters with EGFR-kinase inhibitors
US20050207983A1 (en) 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
SI1756594T1 (sl) 2004-05-25 2010-08-31 Enel Distribuzione Spa Postopek in aparat za odkrivanje faze oĺ˝iäśenja poljubne neznane fazne napetosti glede na referenäśno fazno napetost
WO2005123064A1 (en) * 2004-06-10 2005-12-29 Board Of Trustees Of Michigan State University Adrenergic complement inhaler comprising compounds such as ascorbates tocopherols or polycaboxylic acid chelators
US8627821B2 (en) * 2005-01-10 2014-01-14 Pulmatrix, Inc. Method and device for decreasing contamination
EP2308469A1 (en) * 2005-05-18 2011-04-13 Pulmatrix, Inc. Formulations for alteration of biophysical properties of mucosal lining
KR101360803B1 (ko) 2005-08-15 2014-02-11 베링거 인겔하임 인터내셔날 게엠베하 베타모방제의 제조방법
KR20080067699A (ko) * 2005-11-09 2008-07-21 베링거 인겔하임 인터내셔날 게엠베하 흡입용 에어로졸 제형
EP2026785A1 (de) 2006-05-19 2009-02-25 Boehringer Ingelheim International GmbH Treibgasfreie aerosolformulierung für die inhalation enthaltend ipratropiumbromid und salbutamolsulfat
EP2026784A1 (de) * 2006-05-19 2009-02-25 Boehringer Ingelheim International GmbH Aerosolformulierung enthaltend ipratropiumbromid und salbutamolsulfat
DE102006023756A1 (de) * 2006-05-20 2007-11-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ethanolhaltige Aerosolformulierung für die Inhalation
UY30542A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas
WO2009035711A2 (en) * 2007-09-13 2009-03-19 Medtronic, Inc. Medical electrical lead with jacketed conductive elements
FR2924344B1 (fr) * 2007-12-04 2010-04-16 Pf Medicament Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP2432531B1 (de) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
AP3141A (en) 2009-11-25 2015-02-28 Boehringer Ingelheim Int Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
CN105640925B (zh) 2010-08-30 2019-08-16 普马特里克斯营业公司 干燥粉末配方及用于治疗肺部疾病的方法
US8758824B2 (en) 2010-08-30 2014-06-24 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
WO2012050945A1 (en) 2010-09-29 2012-04-19 Pulmatrix, Inc. Cationic dry powders
AU2011308865B2 (en) 2010-09-29 2017-01-05 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
EP2704724B1 (en) * 2011-05-03 2016-10-26 Chiesi Farmaceutici S.p.A. Improved suspension formulation of beclometasone dipropionate for administration by inhalation
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
AU2013225982B2 (en) 2012-02-29 2017-11-30 Pulmatrix, Inc. Inhalable dry powders
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
RU2479304C1 (ru) * 2012-05-29 2013-04-20 Шолекс Девелопмент Гмбх, Стабильный раствор фенотерола гидробромида
RU2493827C1 (ru) * 2012-10-03 2013-09-27 Шолекс Девелопмент Гмбх Стабильный комбинированный раствор фенотерола гидробромида и ипратропия бромида
EP2981247B1 (en) 2013-04-01 2023-06-07 Pulmatrix Operating Company, Inc. Tiotropium dry powders
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
WO2015065219A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Раствор ипратропия бромида
WO2015065223A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Стабильный раствор фенотерола гидробромида
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
JP6580070B2 (ja) 2014-05-07 2019-09-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 容器、ネブライザ、及び使用
WO2015169429A2 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Container, indicator device, and nebulizer
MX2017012272A (es) * 2015-05-18 2018-06-19 Glenmark Specialty Sa Solucion para inhalacion de tiotropio para nebulizacion.
CN109925300A (zh) * 2017-12-19 2019-06-25 北京盈科瑞创新药物研究有限公司 一种福多司坦雾化吸入用溶液制剂及其制备方法
US20230270754A1 (en) 2020-07-31 2023-08-31 Chemo Research, S.L. Combination therapy for inhalation administration

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
DE3431727A1 (de) * 1984-08-29 1986-03-13 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Nasenspray gegen schnupfen und grippe mit einem gehalt an zinkglukonat
JPH0645538B2 (ja) * 1987-09-30 1994-06-15 日本化薬株式会社 ニトログリセリンスプレー剤
GB8825892D0 (en) * 1988-11-04 1988-12-07 Fisons Plc Pharmaceutical composition
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
CA2071837C (en) * 1990-10-16 2001-01-02 Joseph A. Deihl Vitamin-mineral treatment methods and compositions
SK280911B6 (sk) * 1992-12-09 2000-09-12 Boehringer Ingelheim Pharmaceuticals, Inc. Farmaceutický prostriedok
TW431888B (en) * 1994-02-03 2001-05-01 Schering Plough Healthcare Nasal spray compositions
EP0726075A1 (en) * 1995-02-08 1996-08-14 Therapicon Srl Pharmaceutical non-inorganic saline solutions for endonasal administration
DE59609627D1 (de) * 1995-06-27 2002-10-10 Boehringer Ingelheim Pharma Neue stabile arzneimittelzubereitung zur erzeugung treibgasfreier aerosole
DE19536916A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Kg Inhalative Applikation von 2-Amino-6n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol, insbesondere seines (-)-Enantiomeren, sowie deren pharmakologisch verträgliche Säureadditionssalze
DE19536902A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
EP0808627A2 (de) * 1996-05-22 1997-11-26 Hoechst Aktiengesellschaft Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19620509A1 (de) * 1996-05-22 1997-11-27 Hoechst Ag Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
DE19644646A1 (de) * 1996-10-26 1998-04-30 Mann & Hummel Filter Filter, insbesondere zur Filtrierung des Schmieröls einer Brennkraftmaschine
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
US20060239930A1 (en) * 1997-08-04 2006-10-26 Herbert Lamche Process for nebulizing aqueous compositions containing highly concentrated insulin
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20040019073A1 (en) * 2002-04-11 2004-01-29 Boehringer Ingelheim Pharma Gmbh Co. Kg Aerosol formulation for inhalation containing a tiotropium salt

Also Published As

Publication number Publication date
CN1240347A (zh) 2000-01-05
SA97180756B1 (ar) 2006-04-28
EE03949B1 (et) 2003-02-17
BRPI9713596C1 (pt) 2021-05-25
IL130464A0 (en) 2000-06-01
EP0946146A2 (de) 1999-10-06
AR008721A1 (es) 2000-02-09
PE32899A1 (es) 1999-04-23
HK1022846A1 (en) 2000-08-25
SI0946146T1 (en) 2003-10-31
EP1230916A3 (de) 2003-02-05
US20090099225A1 (en) 2009-04-16
JP4659160B2 (ja) 2011-03-30
CA2275392A1 (en) 1998-07-02
NO993004D0 (no) 1999-06-18
HU227012B1 (en) 2010-04-28
HUP0000520A3 (en) 2000-10-30
EG23981A (en) 2008-02-27
BR9713596B8 (pt) 2013-02-19
PL334185A1 (en) 2000-02-14
RS49803B (sr) 2008-06-05
AU740543B2 (en) 2001-11-08
SK282910B6 (sk) 2003-01-09
PL189511B1 (pl) 2005-08-31
SK81499A3 (en) 2000-01-18
US20010008632A1 (en) 2001-07-19
BR9713596B1 (pt) 2013-01-08
TR199901408T2 (xx) 1999-08-23
ID22481A (id) 1999-10-21
ES2196388T3 (es) 2003-12-16
DE19653969A1 (de) 1998-06-25
CN1097455C (zh) 2003-01-01
YU28499A (sh) 2001-09-28
TW438605B (en) 2001-06-07
DE59709722D1 (de) 2003-05-08
RU2219906C2 (ru) 2003-12-27
NO320652B1 (no) 2006-01-09
NO993004L (no) 1999-06-18
BR9713596A (pt) 2000-04-04
NZ336825A (en) 2001-09-28
AU5663698A (en) 1998-07-17
ATE235887T1 (de) 2003-04-15
EP1230916A2 (de) 2002-08-14
HUP0000520A2 (hu) 2000-09-28
US20090185983A1 (en) 2009-07-23
WO1998027959A2 (de) 1998-07-02
UY24813A1 (es) 2000-09-29
CO4920211A1 (es) 2000-05-29
UA64736C2 (uk) 2004-03-15
EE9900307A (et) 2000-02-15
IL130464A (en) 2004-12-15
HRP970694A2 (en) 1998-10-31
BG64433B1 (en) 2005-02-28
KR20000057683A (ko) 2000-09-25
BG103482A (en) 2000-01-31
ZA9711370B (en) 1998-06-22
EP0946146B1 (de) 2003-04-02
HU228494B1 (en) 2013-03-28
JP2001507343A (ja) 2001-06-05
MY124547A (en) 2006-06-30
DK0946146T3 (da) 2003-04-22
CA2275392C (en) 2004-06-29
KR100496723B1 (ko) 2005-06-22
HU0600044D0 (en) 2006-03-28
HRP970694B1 (en) 2005-06-30
WO1998027959A3 (de) 1998-08-13

Similar Documents

Publication Publication Date Title
PT946146E (pt) Utilizacao de composicoes farmaceuticas aquosas para a producao de aerossois isentos de gas propulsante
PT835098E (pt) Nova composicao farmaceutica estavel para a producao de aerossois sem gas propulsante
NO20005218D0 (no) Farmasøytisk aerosolpreparat
EE03664B1 (et) Farmatseutilised aerosoolkompositsioonid
BR9202953A (pt) Adsorvedor para a producao ou a purificacao de um gas
FI945524L (fi) Aerosolilääkekoostumuksia
BR9700829A (pt) Uso de interferon consensus humano para a produção de um medicamento
ID21137A (id) Alat aerosol yang didorong oleh gas terkompresi
BR9400040A (pt) Dispositivo para a produção de embalagem de cigarros
DE69530325D1 (de) Aerosol-arzneiformulierungen
ID27554A (id) Formulasi-formulasi sediaan farmasi untuk aerosol dengan dua atau lebih bahan aktif
PT1105382E (pt) Metodo para a preparacao de citalopran
ATE363340T1 (de) Aerosol-zerstäuber
DE69701636D1 (de) Sprühkopf für aerosoldosen
IT1292330B1 (it) Procedimento per la produzione di pezzi di lamiera piegati
AR014500A1 (es) Un procedimiento para la preparacion de derivados de dicarboxilato de piridina
PT102098A (pt) Sistema para a criacao de polvos
ID28451A (id) Trisiklik piperidin-δ3 sebagai bahan farmasi
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
PT1071674E (pt) Metodo para a producao de clorobenzoxazoles
BR9608905A (pt) Processos para a síntese e para a preparação de um composto
ECSP951374A (es) Composiciones para pulverizaciones nasales
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
MD351F1 (ro) Generator aerosol
BR9406357A (pt) Catalisador para a fabricaçao de gás de sintese